159 related articles for article (PubMed ID: 38221978)
1. Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial.
von Reppert M; Ramakrishnan D; Brüningk SC; Memon F; Abi Fadel S; Maleki N; Bahar R; Avesta AE; Jekel L; Sala M; Lost J; Tillmanns N; Kaur M; Aneja S; Fathi Kazerooni A; Nabavizadeh A; Lin M; Hoffmann KT; Bousabarah K; Swanson KR; Haas-Kogan D; Mueller S; Aboian MS
Neurooncol Adv; 2024; 6(1):vdad172. PubMed ID: 38221978
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of
Ramakrishnan D; Brüningk SC; von Reppert M; Memon F; Maleki N; Aneja S; Kazerooni AF; Nabavizadeh A; Lin M; Bousabarah K; Molinaro A; Nicolaides T; Prados M; Mueller S; Aboian MS
AJNR Am J Neuroradiol; 2024 Apr; 45(4):475-482. PubMed ID: 38453411
[TBL] [Abstract][Full Text] [Related]
3. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
[TBL] [Abstract][Full Text] [Related]
4. Evolution and implementation of radiographic response criteria in neuro-oncology.
Ramakrishnan D; von Reppert M; Krycia M; Sala M; Mueller S; Aneja S; Nabavizadeh A; Galldiks N; Lohmann P; Raji C; Ikuta I; Memon F; Weinberg BD; Aboian MS
Neurooncol Adv; 2023; 5(1):vdad118. PubMed ID: 37860269
[TBL] [Abstract][Full Text] [Related]
5. Interrater reliability of Brain Tumor Reporting and Data System (BT-RADS) in the follow up of adult primary brain tumors: a single institution experience in Italy.
Parillo M; Mallio CA; Pileri M; Dirawe D; Romano A; Bozzao A; Weinberg B; Quattrocchi CC
Quant Imaging Med Surg; 2023 Nov; 13(11):7423-7431. PubMed ID: 37969622
[TBL] [Abstract][Full Text] [Related]
6. Validating Brain Tumor Reporting and Data System (BT-RADS) as a Diagnostic Tool for Glioma Follow-Up after Surgery.
Almalki YE; Basha MAA; Metwally MI; Zeed NA; Nada MG; Alduraibi SK; Morsy AA; Balata R; Al Attar AZ; Amer MM; Farag MAEM; Aly SA; Basha AMA; Hamed EM
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672241
[TBL] [Abstract][Full Text] [Related]
7. Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurements.
D'Arco F; O'Hare P; Dashti F; Lassaletta A; Loka T; Tabori U; Talenti G; Thust S; Messalli G; Hales P; Bouffet E; Laughlin S
Neuroradiology; 2018 Apr; 60(4):427-436. PubMed ID: 29383433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Radiographic Approaches to Assess Treatment Response in Pituitary Adenomas: Is RECIST or RANO Good Enough?
Imber BS; Lin AL; Zhang Z; Keshavamurthy KN; Deipolyi AR; Beal K; Cohen MA; Tabar V; DeAngelis LM; Geer EB; Yang TJ; Young RJ
J Endocr Soc; 2019 Sep; 3(9):1693-1706. PubMed ID: 31528829
[TBL] [Abstract][Full Text] [Related]
9. BI-RADS Density Classification From Areometric and Volumetric Automatic Breast Density Measurements.
Østerås BH; Martinsen AC; Brandal SH; Chaudhry KN; Eben E; Haakenaasen U; Falk RS; Skaane P
Acad Radiol; 2016 Apr; 23(4):468-78. PubMed ID: 26847741
[TBL] [Abstract][Full Text] [Related]
10. Interrater Agreement of BT-RADS for Evaluation of Follow-Up MRI in Treated Primary Brain Tumor Patients.
Essien M; Cooper ME; Gore A; Min TL; Risk BB; Sadigh G; Hu R; Hoch MJ; Weinberg BD
AJNR Am J Neuroradiol; 2024 Apr; ():. PubMed ID: 38684320
[TBL] [Abstract][Full Text] [Related]
11. LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
van Tilburg CM; Kilburn LB; Perreault S; Schmidt R; Azizi AA; Cruz-Martínez O; Zápotocký M; Scheinemann K; Meeteren AYNS; Sehested A; Opocher E; Driever PH; Avula S; Ziegler DS; Capper D; Koch A; Sahm F; Qiu J; Tsao LP; Blackman SC; Manley P; Milde T; Witt R; Jones DTW; Hargrave D; Witt O
BMC Cancer; 2024 Jan; 24(1):147. PubMed ID: 38291372
[TBL] [Abstract][Full Text] [Related]
12. A brain tumor reporting and data system to optimize imaging surveillance and prognostication in high-grade gliomas.
Kim S; Hoch MJ; Peng L; Somasundaram A; Chen Z; Weinberg BD
J Neuroimaging; 2022 Nov; 32(6):1185-1192. PubMed ID: 36045502
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial.
Gahrmann R; van den Bent M; van der Holt B; Vernhout RM; Taal W; Vos M; de Groot JC; Beerepoot LV; Buter J; Flach ZH; Hanse M; Jasperse B; Smits M
Neuro Oncol; 2017 Jun; 19(6):853-861. PubMed ID: 28204639
[TBL] [Abstract][Full Text] [Related]
14. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
15. Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.
Porz N; Habegger S; Meier R; Verma R; Jilch A; Fichtner J; Knecht U; Radina C; Schucht P; Beck J; Raabe A; Slotboom J; Reyes M; Wiest R
PLoS One; 2016; 11(11):e0165302. PubMed ID: 27806121
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas.
Raman F; Mullen A; Byrd M; Bae S; Kim J; Sotoudeh H; Morón FE; Fathallah-Shaykh HM
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444384
[TBL] [Abstract][Full Text] [Related]
17. Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance images.
Tan J; Liu C; Li Y; Ma Y; Xie R; Li Z; Wan H; Lui S; Wu M
Front Immunol; 2022; 13():1029656. PubMed ID: 36591295
[TBL] [Abstract][Full Text] [Related]
18. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
19. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.
Kanaly CW; Mehta AI; Ding D; Hoang JK; Kranz PG; Herndon JE; Coan A; Crocker I; Waller AF; Friedman AH; Reardon DA; Sampson JH
J Neurosurg; 2014 Sep; 121(3):536-42. PubMed ID: 25036205
[TBL] [Abstract][Full Text] [Related]
20. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
